Eldepryl

Active Ingredient(s): Selegiline
FDA Approved: * May 15, 1996
Pharm Company: * SOMERSET
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Eldepryl Overview

Selegiline, also known as L-deprenyl and sold under the brand names Eldepryl and Emsam among others, is a medication which is used in the treatment of Parkinson's disease and major depressive disorder.[1] It is provided in the form of a capsule or tablet taken by mouth for Parkinson's disease and as a patch applied to skin for depression. Selegiline acts as a monoamine oxidase inhibitor, and increases levels of monoamine neurotransmitters in the brain. At typical clinical dose...

Read more Eldepryl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Selegiline

Recent Eldepryl Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Selegiline
  • Capsule: 5mg
  • Film, Extended Release: 12mg/24hr, 6mg/24hr, 9mg/24hr
  • System: 12mg, 6mg, 9mg
  • Tablet: 1.25mg, 5mg
  • Tablet, Orally Disintegrating: 1.25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Eldepryl: (3 results)

Sorted by National Drug Code
  • 39506-011 Eldepryl 5 mg Oral Tablet by Somerset Pharmaceuticals Inc.
  • 39506-022 Eldepryl 5 mg Oral Capsule by Somerset Pharmaceuticals Inc.
  • 49502-420 Eldepryl 5 mg Oral Capsule by Mylan Specialty

Other drugs which contain Selegiline or a similar ingredient: (4 results)